PET/CT scan using FAPI-46 for interstitial lung disease
Treatments studied
Part of Lungs & breathing clinical trials.
This study tests whether a new PET/CT scan using a radioactive tracer called FAPI-46 can better see lung changes in people with interstitial lung disease. It might help doctors understand the disease activity better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a clinical diagnosis of interstitial lung disease
- You have had a chest CT scan within the last 6 months
- You are willing to undergo the study imaging procedure
- You are not pregnant, breastfeeding, or planning to become pregnant during the study
- You agree to use effective contraception if you could become pregnant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new imaging scan (called 18F-FAPI PET/CT) that may help detect scarring in the lungs, heart, or blood vessels. If you have a heart, lung, or blood vessel condition that could cause scarring, this scan might show damage earlier and help doctors plan better treatment.
This trial uses a special PET/MRI scan to look for early signs of lung scarring and inflammation using a “collagen-targeting” tracer. It may help doctors better identify early interstitial lung disease (IL D) and track it over time.
This study tests whether a special PET scan can better show how well chemotherapy given directly into the abdomen is working, compared to standard scans. This may help doctors see changes in tumors earlier and guide treatment.
This trial is testing a new type of PET scan that may help see lung cancer more clearly. It could help doctors understand your cancer better and plan the best treatment.
This trial uses a special PET/CT scan with a tracer called 68Ga-FAPI-46 to see if it can better detect inflammation and scarring (fibrosis) in people with chronic diseases like scleroderma, pulmonary fibrosis, or rheumatoid arthritis. The goal is to improve diagnosis and monitoring.
This study uses a special PET/CT scan (called FAPI) to look at inflammation in people with ANCA-associated vasculitis and interstitial lung disease. It may help doctors see how active the disease is and guide treatment.
Hear when a new Interstitial Lung Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.